Modulname:
ONKO-KISS
Kurzname:
ONKO
Surveillance objective:
Infection-Surveillance
Surveillance principle:
Patient-based (Analysis Department-based)
Patient collective:
- Stationary patients
Short description:
Surveillance of Nosocomial Septicemias and Pneumonias in Iatrogenically Immunosuppressed Patients with Allogeneic and Autologous Stem Cell Transplantation
Detail description:
ONKO-KISS Module (Surveillance of Nosocomial Infections in Patients with Allogeneic and Autologous Stem Cell Transplantation)
At the end of 2000, the ONKO-KISS module was developed within the framework of the Hospital Infection Surveillance System (KISS) of the National Reference Center (NRZ) for the surveillance of nosocomial infections, which has existed since 1997. In 2016, a revision of the existing protocol was implemented.
Patients, both adults and children, who receive allogeneic or autologous bone marrow or blood stem cell transplants have some of the highest infection rates among all internal medicine and specifically oncology patients, particularly during neutropenia. Sepsis and pneumonia are the most common and serious nosocomial (hospital-acquired) infections. The goal of this surveillance is to prevent nosocomial infections by providing relevant infection data essential for making infection prevention decisions. Since the infection rates differ between the two patient groups—those with allogeneic and autologous stem cell transplants—data are collected and analyzed prospectively for each group separately.
In addition, central venous catheters (conventional, partially or fully implanted) play a crucial role in the risk of developing nosocomial infections, which is why these devices are given special consideration in surveillance. By recording neutropenia days, infections and central venous catheters can be linked to this specific risk situation and presented separately.